Surgical Science Sweden AB (publ)
SSE:SUS.ST
179.1 (SEK) • At close February 20, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) SEK.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 882.853 | 802.54 | 366.778 | 104.799 | 101.515 | 65.7 | 57.976 | 51.8 | 46.1 | 41.103 |
| Kosten van de omzet
| 323.966 | 271.023 | 100.836 | 16.435 | 17.935 | -6.219 | -4.143 | -6.3 | -6.3 | 18.17 |
| Brutowinst
| 558.887 | 531.517 | 265.942 | 88.364 | 83.58 | 71.919 | 62.119 | 58.1 | 52.4 | 22.933 |
| Brutowinstmarge
| 0.633 | 0.662 | 0.725 | 0.843 | 0.823 | 1.095 | 1.071 | 1.122 | 1.137 | 0.558 |
| Onderzoek- en ontwikkelingskosten
| 163.993 | 172.786 | 65.707 | 16.567 | 16.947 | 13.744 | 8.349 | 7.798 | 5.918 | 4.065 |
| Algemene en administratieve kosten
| 72.509 | 63.652 | 66.043 | 13.771 | 12.697 | 33.759 | 30.688 | 28.9 | 23.7 | 0 |
| Verkoop- en marketingkosten
| 167.514 | 138.223 | 79.917 | 36.658 | 38.093 | 30.713 | 0 | 0 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 203.607 | 201.875 | 145.96 | 50.429 | 50.79 | 33.759 | 30.688 | 28.9 | 23.7 | 20.895 |
| Overige kosten
| 2.135 | -5.681 | -2.248 | 1.394 | 0.666 | 42.229 | 35.166 | 29.5 | 27 | 0 |
| Bedrijfskosten
| 367.6 | 368.98 | 209.419 | 68.39 | 68.403 | 75.988 | 65.854 | 58.4 | 50.7 | 25.879 |
| Bedrijfsresultaat
| 191.287 | 162.537 | 88.751 | 19.974 | 15.177 | -4.069 | -3.735 | -0.2 | 1.8 | -2.947 |
| Bedrijfsresultaat ratio
| 0.217 | 0.203 | 0.242 | 0.191 | 0.15 | -0.062 | -0.064 | -0.004 | 0.039 | -0.072 |
| Totaal overige inkomsten en kosten netto
| 76.977 | 45.636 | -22.947 | -0.315 | 0.071 | -0.003 | -0.176 | -0.2 | -0.1 | -0.09 |
| Inkomen voor belasting
| 268.264 | 208.173 | 65.804 | 19.659 | 15.248 | -4.072 | -3.911 | -0.5 | 1.6 | -3.037 |
| Inkomen voor belasting ratio
| 0.304 | 0.259 | 0.179 | 0.188 | 0.15 | -0.062 | -0.067 | -0.01 | 0.035 | -0.074 |
| Belastingkosten
| 34.292 | 20.199 | -20.444 | 4.053 | 2.65 | 0.447 | -1.653 | -3.7 | 0.1 | 0 |
| Nettowinst
| 233.972 | 187.974 | 86.248 | 15.606 | 12.598 | -4.519 | -2.258 | 3.3 | 1.6 | -3.037 |
| Nettowinstmarge
| 0.265 | 0.234 | 0.235 | 0.149 | 0.124 | -0.069 | -0.039 | 0.064 | 0.035 | -0.074 |
| WPA (Winst Per Aandeel)
| 4.59 | 3.7 | 2.03 | 0.45 | 0.45 | -0.19 | -0.12 | 0.23 | 0.066 | -0.21 |
| Verwaterde WPA
| 4.59 | 3.69 | 2.02 | 0.45 | 0.43 | -0.18 | -0.12 | 0.23 | 0.066 | -0.21 |
| EBITDA
| 246.9 | 261.063 | 122.268 | 36.95 | 30.365 | 6.059 | 6.912 | 8.5 | 8.9 | 2.038 |
| EBITDA ratio
| 0.28 | 0.325 | 0.333 | 0.353 | 0.299 | 0.092 | 0.119 | 0.164 | 0.193 | 0.05 |